4 completed, 3 withdrawn, 2 terminated, 1 active not recruiting. 11 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 11 | Completed 4, Withdrawn 3, Terminated 2, Active not recruiting 1, Unknown 1 |
Follow Covid19: new trials by email Literature Review of Covid19 trials Research Report on Covid19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix COVID-19 Therapeutic Biologic Mix - NOVAVAX COVID-19 VACCINE plus BCG Vaccine Mix for percutaneous use - Covid19 | Early Phase 1 | Active not recruiting | Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair | 20 | 2025-05-18 | 2026-06-10 |
| S-Nitrosylation Therapy of COVID-19 SNO, Nitrogen gas - SARS-CoV2 Infection, Covid19 | Early Phase 1 | Withdrawn | James Reynolds | 2021-08-05 | 2025-05-07 | |
| Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection Mouthwash Product - Covid19 | Early Phase 1 | Completed | Rutgers, The State University of New Jersey | 34 | 2021-07-21 | 2026-01-30 |
| Safety, Reactogenicity and Immunogenicity Study of ReCOV Recombinant two-component COVID-19 vaccine (CHO cell), Placebo - Covid19 | Early Phase 1 | Completed | Jiangsu Rec-Biotechnology Co., Ltd. | 100 | 2021-06-18 | 2022-09-27 |
| Immune Response to the COVID-19 Vaccine SARS-COV2 Pfizer Vaccine - Covid19, Cancer | Early Phase 1 | Completed | University of Arizona | 20 | 2021-06-07 | 2022-05-20 |
| Povidone-Iodine Rinses in the Management of COVID-19 Povidone-iodine, Placebo - Covid19 | Early Phase 1 | Terminated | St. Paul's Hospital, Canada | 5 | 2021-01-19 | 2022-07-11 |
| Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19 Glycine, N-acetylcysteine, Alanine - Covid19 | Early Phase 1 | Terminated | Baylor College of Medicine | 4 | 2021-01-11 | 2024-06-26 |
| Study on the Use of Sarilumab in Patients With COVID-19 Infection Sarilumab Prefilled Syringe - COVID19 | Early Phase 1 | Withdrawn | ASST Fatebenefratelli Sacco | 2021-01-01 | 2023-02-03 | |
| Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19) Fluoxetine, Placebo - Covid19 | Early Phase 1 | Withdrawn | Milton S. Hershey Medical Center | 2020-11-01 | 2020-12-24 | |
| Intranasal Heparin Tolerability Study Intranasal heparin sodium (porcine) - Covid19 | Early Phase 1 | Completed | Joshua Sharp | 6 | 2020-10-09 | 2021-04-30 |
| Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients recovered covid 19 patients plasma - Covid19 | Early Phase 1 | Unknown | South Valley University | 30 | 2020-05-29 | 2020-08-28 |
COVID-19 (11) · Coronavirus Infections (1) · Dyspnea (1) · Neoplasms (1) · Respiratory Insufficiency (1)
Coronaviridae Infections (11) · Infections (11) · Lung Diseases (11) · Nidovirales Infections (11) · Pneumonia (11) · Pneumonia, Viral (11) · RNA Virus Infections (11) · Respiratory Tract Diseases (11) · Respiratory Tract Infections (11) · Virus Diseases (11) · Coronavirus Infections (10) · Pathological Conditions, Signs and Symptoms (1) · Respiration Disorders (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1)
Acetylcysteine (1) · Alanine (1) · Fluoxetine (1) · Glycine (1) · NVX-CoV2373 adjuvated lipid nanoparticle (1) · Nitrogen (1) · Povidone-Iodine (1) · Saline Solution (1) · sarilumab (1)
ASST Fatebenefratelli Sacco (1) · Baylor College of Medicine (1) · Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair (1) · James Reynolds (1) · Jiangsu Rec-Biotechnology Co., Ltd. (1) · Joshua Sharp (1) · Milton S. Hershey Medical Center (1) · Rutgers, The State University of New Jersey (1) · South Valley University (1) · St. Paul's Hospital, Canada (1) · University of Arizona (1)
United States (7) · Canada (1) · Egypt (1) · Italy (1) · New Zealand (1)
Bill Gurley, PhD (1) · David Alland, MD (1) · Erika Saunders, MD (1) · Massimo Galli, Professor (1) · Padmapriya Banada, PhD (1) · Rachna Shroff, MD (1) · Robert Schilz, DO, PhD (1) · Yingda L Xie, MD (1)
PMID 34013969, PMID 34594036, PMID 36734509, PMID 37162745, PMID 38103161